CanSino Biologics Inc. Stock price

Equities

6185

CNE100003F01

Pharmaceuticals

Delayed Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
15.92 HKD +0.89% Intraday chart for CanSino Biologics Inc. -6.02% -32.40%

Financials

Sales 2023 357M 49.42M 387M Sales 2024 * 958M 133M 1.04B Capitalization 7.57B 1.05B 8.2B
Net income 2023 -1.45B -200M -1.57B Net income 2024 * -307M -42.49M -332M EV / Sales 2023 31.8 x
Net cash position 2023 * 2.43B 337M 2.64B Net cash position 2024 * 1.5B 208M 1.63B EV / Sales 2024 * 6.33 x
P/E ratio 2023
-3.65 x
P/E ratio 2024 *
-11.6 x
Employees 2,291
Yield 2023 *
-
Yield 2024 *
-
Free-Float 39.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.89%
1 week-5.91%
Current month-12.72%
1 month-13.01%
3 months-26.64%
6 months-35.55%
Current year-32.40%
More quotes
1 week
15.34
Extreme 15.34
17.04
1 month
15.34
Extreme 15.34
18.64
Current year
14.80
Extreme 14.8
23.60
1 year
14.80
Extreme 14.8
45.50
3 years
14.80
Extreme 14.8
437.00
5 years
14.80
Extreme 14.8
450.00
10 years
14.80
Extreme 14.8
450.00
More quotes
Managers TitleAgeSince
Founder 62 09-01-12
Founder 51 09-01-12
Chief Executive Officer 60 09-01-12
Members of the board TitleAgeSince
Director/Board Member 53 15-08-31
Chief Operating Officer 61 18-04-30
Founder 64 09-01-12
More insiders
Date Price Change Volume
24-03-28 15.92 +0.89% 789,240
24-03-27 15.78 +2.07% 803,200
24-03-26 15.46 -3.01% 972,800
24-03-25 15.94 -1.97% 566,370
24-03-22 16.26 -4.01% 967,000

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.7 CNY
Average target price
29.8 CNY
Spread / Average Target
+102.71%
Consensus
  1. Stock
  2. Equities
  3. Stock CanSino Biologics Inc. - Hong Kong S.E.